Novartis.com | Contact Us | Help | Site Map | Stay Connected | Large Text VersionRegular Text Version

Welcome to Novartis Oncology - The Global Site for Novartis Oncology

 

 

 

media

Oncology in the News

16-May-2008
XELOX Followed by XELIRI or the Reverse Sequence in Advanced Colorectal Cancer

16-May-2008
Biweekly Carboplatin/Gemcitabine in Patients with Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: Report of Efficacy, Quality of Life and Geriatric Assessment

16-May-2008
Adjuvant intra-arterial hepatic fotemustine for high-risk uveal melanoma patients

16-May-2008
Epidermal Growth Factor Receptor-Directed Therapy in Esophageal Cancer

 

Sign up to receive Oncology news:

Unsubscribe | Privacy

Novartis Oncology Press Releases

4/11/2008
ASA404, a novel cancer agent, begins pivotal trial to explore new approach in treating lung cancer, the leading cause of cancer death

3/10/2008
Femara® helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy

2/28/2008
Everolimus (RAD001) significantly extends progression-free survival in advanced kidney cancer patients after failure of other targeted therapy

12/09/2007
New data show Glivec® halts progression to advanced stages of life-threatening form of leukemia in sixth year of treatment

 

Virtual Press Office

The Virtual Press Office is a unique service designed specifically to meet the needs of journalists from around the world who report on oncology topics for lay and professional audiences.

ABOUT NOVARTIS ONCOLOGY

About Us

We deliver a broad range of innovative therapies, cancer resources and oncology drugs to improve and extend the lives of cancer patients.

RESEARCH INNOVATION

Novartis maintains the most promising oncology drug pipeline in the industry to treat and help people around the world.

CAREERS AT NOVARTIS

Careers at Novartis

Our success depends entirely on the creativity, performance and achievement of our associates at all levels.

INDIA GLIVEC® / GLEEVEC® PATENT CASE

Find out the Novartis perspective and see our demonstrated commitment to providing access to medicines.

 
 

Novartis Oncology

Oncology News is a current news service provided by Doctor's Guide®. Novartis accepts no responsibility for and makes no representations or warranties regarding the content of the information presented.

Ok